X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (16) 16
macaca mulatta (11) 11
viruses (11) 11
simian acquired immunodeficiency syndrome - virology (10) 10
simian acquired immunodeficiency syndrome - immunology (9) 9
simian immunodeficiency virus - genetics (9) 9
virology (9) 9
index medicus (8) 8
pathogenesis and immunity (8) 8
hiv-1 infection (7) 7
humans (7) 7
infections (7) 7
multidisciplinary sciences (7) 7
simian immunodeficiency virus - immunology (7) 7
antibodies (6) 6
hiv-1 - genetics (6) 6
hiv-1 - pathogenicity (6) 6
simian immunodeficiency virus - pathogenicity (6) 6
antibodies, neutralizing - immunology (5) 5
biological sciences (5) 5
cd4 lymphocyte count (5) 5
cd4 t-cells (5) 5
hiv infections - virology (5) 5
shivs (5) 5
virus diseases (5) 5
aids (4) 4
clinical-outcomes (4) 4
hiv (4) 4
hiv 1 (4) 4
hiv antibodies - blood (4) 4
hiv antibodies - immunology (4) 4
hiv infection (4) 4
hiv infections - immunology (4) 4
hiv-1 - immunology (4) 4
human immunodeficiency virus--hiv (4) 4
human-immunodeficiency-virus (4) 4
in-vivo (4) 4
macaques (4) 4
neutralizing antibodies (4) 4
prevention (4) 4
recombination, genetic (4) 4
research (4) 4
viral antibodies (4) 4
active antiretroviral therapy (3) 3
antibodies, neutralizing - blood (3) 3
blood plasma (3) 3
cd4-positive t-lymphocytes - immunology (3) 3
cd8-positive t-lymphocytes - immunology (3) 3
chimera (3) 3
disease progression (3) 3
health aspects (3) 3
hiv - immunology (3) 3
hiv antibodies - administration & dosage (3) 3
hiv envelope protein gp120 - genetics (3) 3
hiv envelope protein gp120 - immunology (3) 3
immunization, passive (3) 3
lymphocytes (3) 3
male (3) 3
monkeys (3) 3
monkeys & apes (3) 3
monoclonal-antibodies (3) 3
polymerase chain reaction (3) 3
rhesus-monkeys (3) 3
simian acquired immunodeficiency syndrome - blood (3) 3
simian acquired immunodeficiency syndrome - prevention & control (3) 3
simian immunodeficiency virus (3) 3
simian/human immunodeficiency virus (3) 3
t lymphocytes (3) 3
type-1 infection (3) 3
vaccines (3) 3
viremia (3) 3
aids vaccines (2) 2
aids vaccines - immunology (2) 2
amino acid sequence (2) 2
anti-hiv agents - therapeutic use (2) 2
antibodies, monoclonal - immunology (2) 2
antibodies, neutralizing - administration & dosage (2) 2
article (2) 2
broad (2) 2
cd8 antigens - immunology (2) 2
coreceptor switch (2) 2
disease models, animal (2) 2
dna (2) 2
envelope glycoprotein (2) 2
female (2) 2
half-life (2) 2
hiv infections - prevention & control (2) 2
hiv-1 - metabolism (2) 2
human immunodeficiency virus (2) 2
immunization (2) 2
immunoglobulins (2) 2
immunophenotyping (2) 2
infection (2) 2
inhibitory concentration 50 (2) 2
leukocytes, mononuclear - virology (2) 2
lymph nodes - virology (2) 2
macaca (2) 2
microbiology (2) 2
molecular sequence data (2) 2
mutation (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 05/2016, Volume 533, Issue 7601, pp. 105 - 109
Despite the success of potent anti-retroviral drugs in controlling human immunodeficiency virus type 1 (HIV-1) infection, little progress has been made in... 
SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS | POTENT | TRANSMISSION | HIV-1/SIV CHIMERIC VIRUS | BROADLY NEUTRALIZING ANTIBODY | MULTIDISCIPLINARY SCIENCES | IMPROVES PROTECTION | PASSIVE TRANSFER | MACAQUES | INFECTION | MONOCLONAL-ANTIBODIES | HIV Antibodies - blood | Antibodies, Neutralizing - administration & dosage | HIV Infections - prevention & control | AIDS Vaccines - immunology | Macaca mulatta - immunology | Half-Life | Male | Antibodies, Monoclonal - blood | HIV Infections - immunology | Macaca mulatta - virology | Antibodies, Neutralizing - immunology | Immunoglobulin Fc Fragments - immunology | HIV Antibodies - immunology | Time Factors | Female | HIV Infections - transmission | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Protein Structure, Tertiary | SAIDS Vaccines - administration & dosage | Immunoglobulin Fc Fragments - chemistry | Antibodies, Neutralizing - genetics | Mutation - genetics | Simian Acquired Immunodeficiency Syndrome - blood | HIV Antibodies - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | Antibodies, Monoclonal - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | HIV Antibodies - genetics | AIDS Vaccines - administration & dosage | Immunoglobulin Fc Fragments - genetics | Antibodies, Neutralizing - blood | Prevention | Viral antibodies | Antibodies | Dosage and administration | HIV infection | Patient outcomes | Monoclonal antibodies | Immunoglobulins | Immunization | Vaccines | Human immunodeficiency virus--HIV | Viral infections
Journal Article
Nature, ISSN 0028-0836, 03/2017, Volume 543, Issue 7646, pp. 559 - 563
Highly potent and broadly neutralizing anti-HIV-1 antibodies (bNAbs) have been used to prevent and treat lentivirus infections in humanized mice, macaques, and... 
SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS | RHESUS-MONKEYS | BROADLY NEUTRALIZING ANTIBODIES | PRIMARY HIV-1 INFECTION | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | CD4(+) T-CELLS | MACAQUES | MONOCLONAL-ANTIBODIES | HUMANIZED MICE | Antibodies, Neutralizing - administration & dosage | CD8-Positive T-Lymphocytes - cytology | Viremia - therapy | Half-Life | Male | HIV - immunology | Macaca mulatta | HIV - drug effects | Anti-HIV Agents - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Simian Immunodeficiency Virus - isolation & purification | HIV Infections - immunology | Antibodies, Neutralizing - immunology | Simian Acquired Immunodeficiency Syndrome - virology | HIV Antibodies - immunology | Antibodies, Neutralizing - therapeutic use | Anti-HIV Agents - therapeutic use | Female | HIV Antibodies - therapeutic use | Simian Acquired Immunodeficiency Syndrome - therapy | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Virus Replication - drug effects | CD4-Positive T-Lymphocytes - cytology | HIV Infections - virology | Virus Replication - immunology | Combined Modality Therapy | HIV - isolation & purification | HIV Antibodies - administration & dosage | Viral Load - immunology | Animals | Simian Acquired Immunodeficiency Syndrome - drug therapy | Simian Acquired Immunodeficiency Syndrome - immunology | HIV Infections - therapy | Immunization, Passive | Viremia - immunology | CD8-Positive T-Lymphocytes - immunology | Viral Load - drug effects | Simian Immunodeficiency Virus - drug effects | Prevention | Viral antibodies | Immune response | Antibodies | Observations | HIV infection | Health aspects | Antigens | Plasma | Infections | Lymphocytes | Immunotherapy
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2011, Volume 108, Issue 50, pp. 20125 - 20129
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 11/2012, Volume 109, Issue 48, pp. 19769 - 19774
The induction of broadly reacting neutralizing antibodies has been a major goal of HIV vaccine research. Characterization of a pathogenic CCR5 (R5)-tropic... 
CELLS | PATHOGENICITY | RAPID DEVELOPMENT | MULTIDISCIPLINARY SCIENCES | VACCINE | SERA | BROAD | HUMAN-IMMUNODEFICIENCY-VIRUS | MONKEYS | TYPE-1 INFECTION | ISOLATE | Biological Sciences
Journal Article
Journal of Virology, ISSN 0022-538X, 08/2012, Volume 86, Issue 16, pp. 8516 - 8526
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
HIV-1 | NEUTRALIZING ANTIBODIES | VIROLOGY | CORECEPTOR SWITCH | ENVELOPE GENE | IN-VIVO | HUMAN MONOCLONAL-ANTIBODY | CD4(+) T-CELLS | AIDS | MONKEYS | INFECTED MACAQUES | Pathogenesis and Immunity
Journal Article
Journal Article
Urology journal, ISSN 1735-1308, 05/2018, Volume 15, Issue 3, p. 116
The aim of this study was to evaluate postacrosomal sheet WW domain binding protein (PAWP) and phospholipase C ? (PLC?) protein expression in patients with... 
Sperm Motility | Sperm Count | Seminal Plasma Proteins - metabolism | Humans | Male | Spermatozoa - metabolism | Case-Control Studies | Sperm Injections, Intracytoplasmic | Carrier Proteins - metabolism | Treatment Failure | Phosphoinositide Phospholipase C - metabolism | Adult | Infertility, Male - metabolism | Proteins | Sperm
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2009, Volume 106, Issue 19, pp. 8015 - 8020
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2012, Volume 109, Issue 48, pp. 19769 - 19774
The induction of broadly reacting neutralizing antibodies has been a major goal of HIV vaccine research. Characterization of a pathogenic CCR5 (R5)-tropic... 
T lymphocytes | Shivs | Neutralizing antibodies | Antibodies | Viruses | Infections | Inhibitory concentration 50 | Physiological immunosuppression | HIV 1 | Blood plasma
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States, ISSN 0027-8424, 11/2012, Volume 109, Issue 48, p. 19769
The induction of broadly reacting neutralizing antibodies has been a major goal of HIV vaccine research. Characterization of a pathogenic CCR5 (R5)-tropic... 
Prevention | Viral antibodies | Rhesus monkey | Physiological aspects | Antibodies | Virulence (Microbiology) | Research | Health aspects | HIV infection
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2012, Volume 109, Issue 48, p. 19769
  The induction of broadly reacting neutralizing antibodies has been a major goal of HIV vaccine research. Characterization of a pathogenic CCR5 (R5)-tropic... 
Human immunodeficiency virus--HIV | Glycoproteins | Monkeys & apes | Polyclonal antibodies | Virology
Journal Article
Journal of Virology, ISSN 0022-538X, 08/2012, Volume 86, Issue 16, pp. 8516 - 8526
There is an urgent need to develop new pathogenic R5 simian/human immunodeficiency viruses (SHIVs) for the evaluation of candidate anti-HIV vaccines in... 
Journal Article